Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01705054 |
Recruitment Status :
Completed
First Posted : October 12, 2012
Last Update Posted : June 22, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Stable Coronary Artery Disease CAD |
Study Type : | Observational |
Actual Enrollment : | 1246 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Angina Prevalence and Provider Evaluation of Angina Relief |
Study Start Date : | July 2013 |
Actual Primary Completion Date : | July 2015 |
Actual Study Completion Date : | July 22, 2015 |

Group/Cohort |
---|
Outpatient Coronary Artery Disease Patient
CAD patients being seen in a participating cardiology office for a scheduled clinic visit who agree to take the survey.
|
- Seattle Angina Questionnaire [ Time Frame: One time cardiology office visit. ]Percentage of patients with frequent angina (>1 episode/week) as measured by the Seattle Angina Questionnaire (SAQ).
- Quality of Life [ Time Frame: One time cardiology office visit. ]Evaluate the impact of frequent angina on Quality of Life (as measured by the SAQ)
- Physician Perspective [ Time Frame: One time cardiology office visit. ]Identifying differences between patients' and cardiologists' assessment of angina control
- Cardiology practices angina control. [ Time Frame: One time cardiology office visit. ]Evaluate the differences in angina control between cardiology practices.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Coronary artery disease patients being seen in a participating cardiology office for a scheduled clinic visit who agree to take the survey.
Exclusion Criteria:
- Too ill to take survey
- Previously completed this survey
- Refused to participate

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01705054
United States, Missouri | |
Saint Luke's Hospital of Kansas City | |
Kansas City, Missouri, United States, 64111 |
Principal Investigator: | John A Spertus, MD, MPH | Saint Luke's Hospital of Kansas City | |
Principal Investigator: | Faraz Kureshi, MD | Saint Luke's Hospital of Kansas City |
Publications:
Responsible Party: | John A. Spertus, MD, MPH, Missouri/Lauer Endowed Chair and Tenured Professor of Medicine, Saint Luke's Health System |
ClinicalTrials.gov Identifier: | NCT01705054 History of Changes |
Other Study ID Numbers: |
IN-US-259-0157 |
First Posted: | October 12, 2012 Key Record Dates |
Last Update Posted: | June 22, 2017 |
Last Verified: | June 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Angina Stable ischemic heart disease Quality of Life Seattle Angina Questionnaire (SAQ) |
Coronary Artery Disease Angina Pectoris Coronary Disease Myocardial Ischemia Heart Diseases Cardiovascular Diseases Arteriosclerosis |
Arterial Occlusive Diseases Vascular Diseases Chest Pain Pain Neurologic Manifestations Signs and Symptoms |